Jiangsu Xiansheng Medical Diagnosis Co. Ltd. is a Chinese company located in Nanjing. The firm develops diagnostic devices.

Hunan Demeter Instrument Co., Ltd., established on 2014-12-23, The business scope includes components for general and special purpose instrumentation,device,Experimental analysis instrument,Medical Laboratory Equipment and Appliances,Chemical Reagents and Auxiliaries(Monitor Chemicals,Excluding hazardous chemicals)manufacture;Class II medical device,Chemical Reagents and Auxiliaries(Monitor Chemicals,Excluding hazardous chemicals),Class I medical device sales;Class I medical device,Class II:6840In vitro diagnostic reagents,Class II medical device,Class II:6840Clinical Laboratory Analytical Instruments,Three types of medical device research and development;Class I medical device,Class II medical device,Production of Class III Medical Devices;Medical Laboratory Technology,Application software development;Retailing of Class III Medical Devices;Medical equipment rental service;Clinical Laboratory Services;Technology project agency service;Medical laboratory technical service;medical information,Technical Advisory Services;Biotechnology Extension Services;Medical device technology promotion service;High-tech entrepreneurship services;research and development,Incubation and Transformation;IC Design;Medical Research and Experimental Development;Service Authentication.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Jiangsu Xiansheng Medical Equipment Co., Ltd., established on 2018-08-29, Business scope includes sales of medical devices(A license or approval is required to operate),research and development,lease,technical consulting,Technical Services;computer,Technology development in the field of biology,Technical Services,technical consulting,technology transfer;Nutrition and Health Consulting;computer,Communication equipment rental;Equipment,Instrumentation,Wujinjiaodian,Chemical Products(Does not contain hazardous chemicals)Sales;Medical technology research and development(Does not include medical services);account Serive,Exhibition display service;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);Medical device production(A license or approval is required to operate).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou HiSilicon Medical Technology Co., Ltd., established on 2014-07-16, The scope of business includes food science and technology research services;drug development;Natural science research and experimental development;Health Sciences Program Research,to develop;Biomedical Technology Research;Medical Research and Experimental Development;Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Technology Import and Export;Import and export(Excluding franchised products);Sales of biological diagnostic reagents and kits(Does not include license approval items);Research and development of biodiagnostic reagents and kits(Does not include license approval items);venture capital;Enterprise own capital investment;Operation of non-licensed medical devices;Biotechnology Transfer Services;software development;Technology Promotion of Research Results of Health Science Projects;Medical Technology Consulting,communication service;Medical technology promotion service;Medical supplies and equipment retail(Does not contain drugs and medical devices);Information Technology Consulting Services;Data Processing and Storage Services;Commodity wholesale trade(Except for licensed and approved products);nursing service(does not involve accommodation,medical diagnosis,Treatment and Rehabilitation Services);Flower Crops Wholesale;medical diagnosis,Monitoring and treatment equipment manufacturing;Biopharmaceutical Manufacturing;Clinical Laboratory Services;Mental Rehabilitation Services;the elderly,Care Services for the Disabled(Does not involve a medical diagnosis,Treatment and Rehabilitation Services);medical diagnosis,Monitoring and treatment equipment wholesale;medical diagnosis,Monitoring and treatment equipment retail

Bioprojet SCR is a French private company located in Paris, with subsidiaries in France, that provides research and development services.

At Zogenix, our core strategy is to develop and commercialize differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products. We are a specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. Our lead product candidate, sumatriptan DoseProâ„¢, enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine. Our second product candidate, ZX002, is a novel controlled release formulation of hydrocodone for the treatment of chronic pain.

Nanjing Xiansheng Medical Laboratory Co., Ltd., established on 2017-07-04, Business scope includes medical examination(Must obtain a license or approval before engaging in business activities);Medical Device Sales(Licensed items must obtain a license or approval before engaging in business activities),technology development,technical consulting,Technical Services;computer technology development,technical consulting,Technical Services,technology transfer;Health Information Consultation;biotechnology development,Technical Services,technical consulting,technology transfer;medical instruments,computer,Communication equipment rental;Equipment,Industrial Automation Equipment,Instrumentation,Wujinjiaodian,Chemical Products(Does not contain hazardous chemicals)Sales;Expo Services;Self-operated and agent import and export business of various commodities and technologies(Except where the state restricts enterprises to operate or prohibits the import and export of commodities and technologies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Taizhou Daoye Technology Co., Ltd., established on 2018-03-22, Business scope includes computer network,electronic product,Biotechnology R&D,technology transfer,technical consulting,Technical Services;Industrial Design Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Forschungsverbund Berlin conducts basic research in molecular pharmacology with the aim of identifying new bioactive molecules and characterizing their interactions with their biological targets in cells or organisms. The compounds are useful in basic biomedical research and may also be used to treat, prevent, or diagnose diseases. Also, they develop and use advanced technologies, which range from screening technologies to NMR-based methods to proteomics and in vivo models.

Nordic Bioscience is a biotech firm that studies extracellular matrix (ECM). It uses Protein Fingerprint technology to identify ECM fragments released from affected tissues and to develop blood-based biomarker assays to quantify disease activity in the pursuit of precision medicine. Nordic Bioscience is based in Herlev, Denmark, and operates a high-quality standard laboratory that conducts clinical trials in accordance with Good Clinical Laboratory Practice (GCLP) and is accredited by the College of American Pathologists (CAP), and has an ISO9001 certificate.

Hangzhou Aofei Biotechnology Co., Ltd., established on 2020-09-08, Business scope includes general items:Disinfectant sales(Free of Hazardous Chemicals);Production of Class I Medical Devices;Sales of Class I Medical Devices;Engineering and Technology Research and Experimental Development;Sales of daily chemical products;Manufacturing of daily chemical products;Cosmetics Retail;Cosmetics Wholesale;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Sales of Class II Medical Devices;Machinery sales;Drug testing equipment sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.

Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA.

Pujiang Yishuo Technology Development Co., Ltd., established on 2018-06-04, Business scope includes energy saving and emission reduction technologies,Pollutant Treatment Technology,Electronics and Information Technology,Equipment,medical equipment,Water conservancy project,Technological Development of Construction Engineering,Technology Promotion,Technology transfer and technical consulting services;Industrial product design and consulting services;Science and Technology Information Consulting Services,Technology project declaration agency service,Technology development results transfer consulting services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Clera Inc. operates as a drug discovery and development company that creates medicines for aging related illness of the mind. It targets aging related markets of Parkinson��s disease, cognition, Alzheimer��s and depression. The company was founded by Robley L. Seeman and Philip Seeman in 2001 and is headquartered in Toronto, Canada.

nLife Therapeutics, S.L., a Granada, Spain-based company that develops innovative tratments for CNS diseases. The company intends to use the funds to advance clinical trials for its treatments. nLife Therapeutics is working on next generation targeted nucleic acids products. Its technology delivers conjugated nucleic acids with small chemicals to selected neurons after a single intra-nasal application.

Foshan No. 1 People's Hospital, a subsidiary of Sun Yat-Sen University, is a company headquartered in Foshan, China. The firm provides healthcare services.

Beijing Huakang Chengxin Medical Technology Co., Ltd., established on 2008-04-21, Business scope includes research and development of pharmacy automation equipment,production and sales;Import and export,Technology Import and Export,Agent import and export;Intelligent Material Handling Equipment Manufacturing;technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;software development;selling computers,Software and Auxiliary Equipment,medical instrumentsIkind,self-developed products.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Changzhou Qingmu Automatic Door Co., Ltd., established on 2011-12-19, The scope of business includes automatic doors,Medical door production,Processing and sales;sheet metal parts,stainless steel plate,Stainless Steel Products,Fabrication of steel structure parts,processing;Design and construction of interior and exterior decoration projects.Manufacture of civil air defense engineering protective equipment;Various construction activities;Door and window manufacturing;Door and window sales;Production of special labor protection products;Production of protective equipment for medical personnel(Ι class medical device);(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)